2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow LianBio LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study Lotilaner, Vehicle Control - Blepharitis | Phase 3 | Completed | LianBio LLC | 163 | 2022-10-23 | 2024-05-21 |
| A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM Mavacamten, Placebo - Obstructive Hypertrophic Cardiomyopathy | Phase 3 | Completed | LianBio LLC | 81 | 2022-01-04 | 2024-09-19 |
Blepharitis (1) · Cardiomyopathy, Hypertrophic (1)
China (2)
Shuyang Zhang, M.D., Ph.D. (1) · Zuguo Liu, M.D (1)
PMID 37336533, PMID 37639259, PMID 40299193, PMID 40632050, PMID 42165935, PMID 42179278, PMID 42636950